INCOME STATEMENT (Quarterly GAAP In millions $) |
(Mar 30 2024) I. Quarter |
(Dec 30 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jul 01 2023) II. Quarter |
(Apr 01 2023) I. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
10.03 |
|
10.60 |
10.46 |
10.76 |
Interest Income, Operating |
0.17 |
|
0.30 |
0.22 |
0.10 |
Revenue From Contract With Customer Including Assessed Tax |
- |
|
- |
- |
- |
Other Revenue |
0.00 |
|
0.00 |
0.00 |
0.00 |
Total Revenue |
10.21 |
8.78 |
10.90 |
10.68 |
10.86 |
Cost of Goods and Services Sold |
- |
- |
- |
- |
- |
Gross
Profit |
10.21 |
8.78 |
10.90 |
10.68 |
10.86 |
Selling, Administration, Marketing |
7.23 |
5.93 |
4.80 |
6.47 |
4.65 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
2.10 |
-4.93 |
3.09 |
3.13 |
2.31 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
8.71 |
14.58 |
5.74 |
5.92 |
6.73 |
Litigation Settlement, Expense |
24.80 |
- |
- |
- |
- |
Total operating costs including COS |
42.85 |
15.57 |
13.63 |
15.52 |
13.69 |
Operating income/-loss
|
-32.64 |
-6.79 |
-2.73 |
-4.84 |
-2.83 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Gain (Loss) on Investments |
- |
- |
- |
-3.33 |
- |
Foreign Currency Transaction Gain (Loss), Realized |
-0.08 |
-0.01 |
-0.01 |
-0.24 |
0.10 |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.01 |
-0.33 |
-0.30 |
6.87 |
-0.33 |
Total costs & expenses |
42.75 |
15.23 |
13.31 |
18.82 |
13.45 |
Income /-loss before income taxes |
-32.55 |
-6.45 |
-2.41 |
-8.14 |
-2.59 |
Income taxes expenses/-benefit |
- |
0.04 |
0.04 |
0.04 |
0.04 |
Income after income taxes |
-32.55 |
-6.49 |
-2.45 |
-8.18 |
-2.63 |
Net income/-loss
of other equity |
- |
0.00 |
- |
- |
- |
Income Before Minority Interest Earnings And Equity Investments |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-32.55 |
-6.49 |
-2.45 |
-8.18 |
-2.63 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-32.55 |
-6.49 |
-2.45 |
-8.18 |
-2.63 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-32.55 |
-6.49 |
-2.45 |
-8.18 |
-2.63 |
EBIT |
-32.55 |
-6.45 |
-2.41 |
-8.14 |
-2.59 |
EBITD |
-32.35 |
-6.34 |
-2.30 |
-7.98 |
-2.36 |
EBITDA |
-32.35 |
-6.34 |
-2.30 |
-7.98 |
-2.36 |